Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 20Stomach Neoplasms 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma 6Neoplasms, Plasma Cell 4Recurrence 3Dyspepsia 3Peptic Ulcer 2Gastritis 2Skin Neoplasms 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Infections 1Helicobacter Infections 1Familial primary gastric lymphoma 1Drug-Related Side Effects and Adverse Reactions 1Chemotherapy Effect 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1B-cell Malignancies 1Atrophy 1

Interventions

Mitomycin 3Hyperthermic Intraperitoneal Chemotherapy 3Surveys and Questionnaires 2Oxaliplatin 2Leucovorin 2Fluorouracil 2Capecitabine 2Bromelains 2Acetylcysteine 2tislelizumab 1molgramostim 1irinotecan sucrosofate 1cryoprecipitate coagulum 1Tacrolimus 1Standard of Care 1Specimen Handling 1Sirolimus 1Referral and Consultation 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Observation 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Lansoprazole 1Ipilimumab 1Ifosfamide 1Gemcitabine 1Floxuridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Clarithromycin × Clear all
NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Mercy Medical Center

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡